1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe OTC Drug and Dietary Supplement Market – By Product
1.3.2 Europe OTC Drug and Dietary Supplement Market – By Type
1.3.3 Europe OTC Drug and Dietary Supplement Market – By Form
1.3.4 Europe OTC Drug and Dietary Supplement – By Distribution Channel
1.3.5 Europe OTC Drug and Dietary Supplement Market– By Region

2. OTC Drug and Dietary Supplement Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. OTC Drug and Dietary Supplement – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion

5. Europe OTC Drug and Dietary Supplement Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Rising General Health Issues
5.1.2 Preference for OTC Drugs
5.2 Market Restraints
5.2.1 Stringent Government Regulations For OTC Drugs
5.3 Market Opportunities
5.3.1 Business Expansion Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Preference of OTC Drugs for Minor Diseases
5.5 Impact Analysis

6. OTC Drug and Dietary Supplement Market – Regional Analysis
6.1 Europe OTC Drug and Dietary Supplement Market Revenue Forecast And Analysis

7. Europe OTC Drug and Dietary Supplement Market Analysis – By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

8. OTC Drug and Dietary Supplement Analysis – By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

9. OTC Drug and Dietary Supplement Analysis – By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

10. OTC Drug and Dietary Supplement Analysis – By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)

11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 – Geographical Analysis
11.1 Europe: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 Europe: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.4 Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.6 Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.11 Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Italy: OTC Drug and Dietary Supplement Market,– Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.12 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Spain: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AbbVie Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bayer AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Procter & Gamble
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 Glossary of Terms
14.1.1 Glossary of Terms, OTC Drug and Dietary Supplement

Figure 1. OTC Drug and Dietary Supplement Market Segmentation
Figure 2. OTC Drug and Dietary Supplement Segmentation – By Region
Figure 3. Europe OTC Drug and Dietary Supplement Market Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. OTC Drug and Dietary Supplement Market in Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe OTC Drug and Dietary Supplement Market- Leading Country Markets (US$ Million)
Figure 7. Europe PEST Analysis
Figure 8. OTC Drug and Dietary Supplement Impact Analysis Of Driver And Restraints
Figure 9. Europe OTC Drug and Dietary Supplement Market – Revenue Forecast And Analysis – 2019- 2027
Figure 10. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 11. Cough and Cold Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Analgesics: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Gastrointestinal Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Sleep Aids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Oral Care Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ophthalmic Products: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Antacids: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Feminine Care: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 21. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 22. Branded: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Generic: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 24. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 25. Tablets: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Capsules: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Powders: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Ointments: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 31. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 32. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Retail Stores: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Online Channels: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Others: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Europe: OTC Drug and Dietary Supplement Market, by Key Country – Revenue (2019) (USD Million)
Figure 37. Europe: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 39. Germany: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 40. France: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: OTC Drug and Dietary Supplement Market, – Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: OTC Drug and Dietary Supplement – Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic on OTC Drug And Dietary Supplement Market in European Countries

Table 1. Europe: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. France: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. France: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. France: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 12. France: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. UK: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. UK: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 16. UK: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Spain: OTC Drug and Dietary Supplement Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Spain: OTC Drug and Dietary Supplement Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Spain: OTC Drug and Dietary Supplement Market, by Form – Revenue and Forecast to 2027 (USD Million)
Table 24. Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

The List of Companies - Europe OTC Drug and Dietary Supplement Market
1. GlaxoSmithKline plc.
2. Sanofi
3. Johnson and Johnson Services, Inc.
4. Abbott
5. AbbVie Inc.
6. Bausch Health Companies Inc.
7. Bayer AG
8. Procter & Gamble
9. Novartis AG
10. Reckitt Benckiser Group Plc